Annual EBIT
-$7.28 M
+$2.96 M+28.90%
December 31, 2023
Summary
- As of February 7, 2025, TTNP annual earnings before interest & taxes is -$7.28 million, with the most recent change of +$2.96 million (+28.90%) on December 31, 2023.
- During the last 3 years, TTNP annual EBIT has risen by +$74.00 thousand (+1.01%).
- TTNP annual EBIT is now -267.56% below its all-time high of $4.34 million, reached on December 31, 2016.
Performance
TTNP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$754.00 K
+$1.32 M+63.65%
September 30, 2024
Summary
- As of February 7, 2025, TTNP quarterly earnings before interest & taxes is -$754.00 thousand, with the most recent change of +$1.32 million (+63.65%) on September 30, 2024.
- Over the past year, TTNP quarterly EBIT has increased by +$1.18 million (+60.95%).
- TTNP quarterly EBIT is now -105.67% below its all-time high of $13.30 million, reached on December 31, 1997.
Performance
TTNP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$5.82 M
+$1.31 M+18.33%
September 30, 2024
Summary
- As of February 7, 2025, TTNP TTM earnings before interest & taxes is -$5.82 million, with the most recent change of +$1.31 million (+18.33%) on September 30, 2024.
- Over the past year, TTNP TTM EBIT has increased by +$1.46 million (+19.99%).
- TTNP TTM EBIT is now -194.50% below its all-time high of $6.16 million, reached on June 30, 2016.
Performance
TTNP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TTNP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.9% | +61.0% | +20.0% |
| 3 y3 years | +1.0% | +70.3% | +37.1% |
| 5 y5 years | +11.9% | +71.4% | +12.7% |
TTNP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.9% | at high | +71.5% | at high | +43.1% |
| 5 y | 5-year | -11.6% | +28.9% | -114.3% | +75.8% | -746.2% | +43.1% |
| alltime | all time | -267.6% | +77.3% | -105.7% | +94.2% | -194.5% | +82.2% |
Titan Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$754.00 K(-63.6%) | -$5.82 M(-18.3%) |
| Jun 2024 | - | -$2.07 M(+95.1%) | -$7.13 M(+7.3%) |
| Mar 2024 | - | -$1.06 M(-45.0%) | -$6.64 M(-8.7%) |
| Dec 2023 | -$7.28 M(-28.9%) | -$1.93 M(-6.3%) | -$7.28 M(-8.5%) |
| Sep 2023 | - | -$2.06 M(+29.8%) | -$7.96 M(-6.8%) |
| Jun 2023 | - | -$1.59 M(-6.4%) | -$8.54 M(-9.1%) |
| Mar 2023 | - | -$1.70 M(-35.0%) | -$9.39 M(-8.2%) |
| Dec 2022 | -$10.23 M(+9.4%) | -$2.61 M(-1.2%) | -$10.23 M(+1.2%) |
| Sep 2022 | - | -$2.64 M(+8.2%) | -$10.11 M(+7.8%) |
| Jun 2022 | - | -$2.44 M(-3.8%) | -$9.38 M(+1.3%) |
| Mar 2022 | - | -$2.54 M(+2.0%) | -$9.26 M(-1.1%) |
| Dec 2021 | -$9.35 M(+27.2%) | -$2.49 M(+30.5%) | -$9.36 M(+16.1%) |
| Sep 2021 | - | -$1.91 M(-17.9%) | -$8.07 M(+9.5%) |
| Jun 2021 | - | -$2.33 M(-11.9%) | -$7.37 M(+10.5%) |
| Mar 2021 | - | -$2.64 M(+121.3%) | -$6.67 M(-6.6%) |
| Dec 2020 | -$7.35 M(+12.7%) | -$1.19 M(-1.3%) | -$7.14 M(+937.5%) |
| Sep 2020 | - | -$1.21 M(-25.6%) | -$688.00 K(-66.3%) |
| Jun 2020 | - | -$1.63 M(-47.8%) | -$2.04 M(-61.9%) |
| Mar 2020 | - | -$3.11 M(-159.2%) | -$5.36 M(-17.8%) |
| Dec 2019 | -$6.52 M(-21.1%) | $5.26 M(-305.0%) | -$6.52 M(-56.6%) |
| Sep 2019 | - | -$2.56 M(-48.1%) | -$15.05 M(+4.2%) |
| Jun 2019 | - | -$4.94 M(+15.8%) | -$14.43 M(+42.5%) |
| Mar 2019 | - | -$4.27 M(+30.8%) | -$10.13 M(+22.6%) |
| Dec 2018 | -$8.26 M(-43.0%) | -$3.27 M(+67.3%) | -$8.26 M(-1.3%) |
| Sep 2018 | - | -$1.95 M(+205.5%) | -$8.37 M(-20.2%) |
| Jun 2018 | - | -$639.00 K(-73.5%) | -$10.49 M(-22.1%) |
| Mar 2018 | - | -$2.41 M(-28.7%) | -$13.47 M(-7.1%) |
| Dec 2017 | -$14.50 M(-433.9%) | -$3.37 M(-17.1%) | -$14.50 M(+0.8%) |
| Sep 2017 | - | -$4.07 M(+12.4%) | -$14.38 M(+11.2%) |
| Jun 2017 | - | -$3.62 M(+5.4%) | -$12.93 M(-572.3%) |
| Mar 2017 | - | -$3.44 M(+5.6%) | $2.74 M(-37.0%) |
| Dec 2016 | $4.34 M(-164.3%) | -$3.25 M(+24.4%) | $4.34 M(-18.8%) |
| Sep 2016 | - | -$2.62 M(-121.7%) | $5.35 M(-13.2%) |
| Jun 2016 | - | $12.04 M(-757.8%) | $6.16 M(-188.3%) |
| Mar 2016 | - | -$1.83 M(-18.6%) | -$6.97 M(+3.2%) |
| Dec 2015 | -$6.76 M(+94.5%) | -$2.25 M(+24.9%) | -$6.76 M(+17.3%) |
| Sep 2015 | - | -$1.80 M(+65.0%) | -$5.76 M(+22.6%) |
| Jun 2015 | - | -$1.09 M(-32.4%) | -$4.70 M(+13.0%) |
| Mar 2015 | - | -$1.61 M(+28.9%) | -$4.16 M(+19.6%) |
| Dec 2014 | -$3.48 M(+290.0%) | -$1.25 M(+69.8%) | -$3.48 M(+21.3%) |
| Sep 2014 | - | -$738.00 K(+34.2%) | -$2.86 M(+27.1%) |
| Jun 2014 | - | -$550.00 K(-41.1%) | -$2.25 M(+12.9%) |
| Mar 2014 | - | -$934.00 K(+45.5%) | -$2.00 M(+124.0%) |
| Dec 2013 | -$891.00 K(-89.4%) | -$642.00 K(+401.6%) | -$891.00 K(+29.1%) |
| Sep 2013 | - | -$128.00 K(-56.2%) | -$690.00 K(-78.6%) |
| Jun 2013 | - | -$292.00 K(-270.8%) | -$3.22 M(-31.0%) |
| Mar 2013 | - | $171.00 K(-138.8%) | -$4.67 M(-44.7%) |
| Dec 2012 | -$8.37 M(-20.3%) | -$441.00 K(-83.4%) | -$8.44 M(-3.7%) |
| Sep 2012 | - | -$2.66 M(+52.8%) | -$8.76 M(+8.7%) |
| Jun 2012 | - | -$1.74 M(-51.7%) | -$8.06 M(-23.4%) |
| Mar 2012 | - | -$3.60 M(+370.0%) | -$10.52 M(+0.2%) |
| Dec 2011 | -$10.51 M(+70.7%) | -$766.00 K(-60.9%) | -$10.51 M(-24.2%) |
| Sep 2011 | - | -$1.96 M(-53.4%) | -$13.86 M(+15.1%) |
| Jun 2011 | - | -$4.20 M(+17.2%) | -$12.03 M(+25.9%) |
| Mar 2011 | - | -$3.58 M(-12.9%) | -$9.56 M(+55.3%) |
| Dec 2010 | -$6.16 M(+5.9%) | -$4.12 M(+2948.1%) | -$6.16 M(+78.7%) |
| Sep 2010 | - | -$135.00 K(-92.2%) | -$3.44 M(-29.6%) |
| Jun 2010 | - | -$1.73 M(+858.9%) | -$4.89 M(-0.3%) |
| Mar 2010 | - | -$180.00 K(-87.2%) | -$4.91 M(-15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$5.82 M(-68.5%) | -$1.40 M(-11.5%) | -$5.82 M(+31.8%) |
| Sep 2009 | - | -$1.58 M(-8.9%) | -$4.41 M(-50.1%) |
| Jun 2009 | - | -$1.74 M(+60.1%) | -$8.85 M(-40.9%) |
| Mar 2009 | - | -$1.09 M(-81.9%) | -$14.96 M(-42.9%) |
| Sep 2008 | - | -$6.02 M(-23.3%) | -$26.19 M(+5.9%) |
| Jun 2008 | - | -$7.85 M(+31.8%) | -$24.73 M(+18.4%) |
| Mar 2008 | - | -$5.95 M(-6.5%) | -$20.89 M(+13.4%) |
| Dec 2007 | -$18.43 M(+12.1%) | -$6.37 M(+39.6%) | -$18.43 M(+18.7%) |
| Sep 2007 | - | -$4.56 M(+13.6%) | -$15.53 M(+0.1%) |
| Jun 2007 | - | -$4.01 M(+14.9%) | -$15.52 M(+2.6%) |
| Mar 2007 | - | -$3.49 M(+0.8%) | -$15.12 M(-8.1%) |
| Dec 2006 | -$16.45 M(-28.6%) | -$3.46 M(-23.9%) | -$16.45 M(-4.4%) |
| Sep 2006 | - | -$4.55 M(+25.9%) | -$17.20 M(-10.4%) |
| Jun 2006 | - | -$3.61 M(-25.0%) | -$19.19 M(-10.4%) |
| Mar 2006 | - | -$4.82 M(+14.3%) | -$21.42 M(-7.1%) |
| Dec 2005 | -$23.05 M(-10.0%) | -$4.22 M(-35.5%) | -$23.05 M(-11.5%) |
| Sep 2005 | - | -$6.54 M(+11.8%) | -$26.03 M(+1.2%) |
| Jun 2005 | - | -$5.85 M(-9.3%) | -$25.72 M(+0.5%) |
| Mar 2005 | - | -$6.45 M(-10.5%) | -$25.59 M(-0.1%) |
| Dec 2004 | -$25.62 M(-6.1%) | -$7.20 M(+15.7%) | -$25.62 M(+1.6%) |
| Sep 2004 | - | -$6.22 M(+8.9%) | -$25.21 M(-1.1%) |
| Jun 2004 | - | -$5.72 M(-11.8%) | -$25.49 M(-4.8%) |
| Mar 2004 | - | -$6.48 M(-4.6%) | -$26.76 M(-1.9%) |
| Dec 2003 | -$27.28 M(-14.8%) | -$6.79 M(+4.4%) | -$27.28 M(-7.9%) |
| Sep 2003 | - | -$6.50 M(-7.0%) | -$29.63 M(-5.9%) |
| Jun 2003 | - | -$6.99 M(-0.1%) | -$31.48 M(-3.6%) |
| Mar 2003 | - | -$7.00 M(-23.4%) | -$32.65 M(+2.0%) |
| Dec 2002 | -$32.00 M(+32.5%) | -$9.14 M(+9.3%) | -$32.00 M(+3.9%) |
| Sep 2002 | - | -$8.36 M(+2.4%) | -$30.80 M(+6.3%) |
| Jun 2002 | - | -$8.16 M(+28.5%) | -$28.98 M(+18.3%) |
| Mar 2002 | - | -$6.35 M(-19.9%) | -$24.50 M(+1.4%) |
| Dec 2001 | -$24.15 M(+27.5%) | -$7.93 M(+21.3%) | -$24.15 M(+10.9%) |
| Sep 2001 | - | -$6.54 M(+77.7%) | -$21.77 M(+6.9%) |
| Jun 2001 | - | -$3.68 M(-38.7%) | -$20.36 M(-0.0%) |
| Mar 2001 | - | -$6.00 M(+8.2%) | -$20.37 M(+7.6%) |
| Dec 2000 | -$18.93 M(+59.1%) | -$5.55 M(+8.2%) | -$18.93 M(+14.2%) |
| Sep 2000 | - | -$5.13 M(+39.0%) | -$16.58 M(+19.7%) |
| Jun 2000 | - | -$3.69 M(-19.2%) | -$13.86 M(+3.7%) |
| Mar 2000 | - | -$4.57 M(+42.7%) | -$13.37 M(+14.7%) |
| Dec 1999 | -$11.90 M(+4.4%) | -$3.20 M(+33.3%) | -$11.65 M(-2.5%) |
| Sep 1999 | - | -$2.40 M(-25.0%) | -$11.95 M(-3.2%) |
| Jun 1999 | - | -$3.20 M(+12.1%) | -$12.35 M(+6.9%) |
| Mar 1999 | - | -$2.85 M(-18.5%) | -$11.55 M(+2.2%) |
| Dec 1998 | -$11.40 M(+46.2%) | -$3.50 M(+25.0%) | -$11.30 M(-305.4%) |
| Sep 1998 | - | -$2.80 M(+16.7%) | $5.50 M(+22.2%) |
| Jun 1998 | - | -$2.40 M(-7.7%) | $4.50 M(+60.7%) |
| Mar 1998 | - | -$2.60 M(-119.5%) | $2.80 M(-137.3%) |
| Dec 1997 | -$7.80 M(-26.4%) | $13.30 M(-450.0%) | -$7.50 M(-69.4%) |
| Sep 1997 | - | -$3.80 M(-7.3%) | -$24.50 M(+5.6%) |
| Jun 1997 | - | -$4.10 M(-68.2%) | -$23.20 M(+7.4%) |
| Mar 1997 | - | -$12.90 M(+248.6%) | -$21.60 M(+109.7%) |
| Dec 1996 | -$10.60 M(+12.8%) | -$3.70 M(+48.0%) | -$10.30 M(-36.0%) |
| Sep 1996 | - | -$2.50 M(0.0%) | -$16.10 M(+19.3%) |
| Jun 1996 | - | -$2.50 M(+56.3%) | -$13.50 M(+23.9%) |
| Mar 1996 | - | -$1.60 M(-83.2%) | -$10.90 M(+18.5%) |
| Dec 1995 | -$9.40 M | -$9.50 M(-9600.0%) | -$9.20 M(-3166.7%) |
| Sep 1995 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Jun 1995 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is Titan Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual EBIT year-on-year change?
- What is Titan Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly EBIT year-on-year change?
- What is Titan Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM EBIT year-on-year change?
What is Titan Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of TTNP is -$7.28 M
What is the all time high annual EBIT for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual earnings before interest & taxes is $4.34 M
What is Titan Pharmaceuticals annual EBIT year-on-year change?
Over the past year, TTNP annual earnings before interest & taxes has changed by +$2.96 M (+28.90%)
What is Titan Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of TTNP is -$754.00 K
What is the all time high quarterly EBIT for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly earnings before interest & taxes is $13.30 M
What is Titan Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, TTNP quarterly earnings before interest & taxes has changed by +$1.18 M (+60.95%)
What is Titan Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of TTNP is -$5.82 M
What is the all time high TTM EBIT for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM earnings before interest & taxes is $6.16 M
What is Titan Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, TTNP TTM earnings before interest & taxes has changed by +$1.46 M (+19.99%)